Additionally, 90% (36/40) of CC patients showed a silent mutation at codon 787 in exon 20, and 83.3% of patients with EGFR mutations showed increased MAPK and AKT phosphorylation [103]. Here, AKT1 is linked to cholangiocarcinoma.